CVRx (CVRX) Competitors $7.87 -0.37 (-4.49%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$7.89 +0.02 (+0.24%) As of 08:29 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVRX vs. AXGN, SIBN, BVS, AVNS, ZIMV, KIDS, TMCI, CBLL, SMLR, and DCTHShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), CeriBell (CBLL), Semler Scientific (SMLR), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. CVRx vs. Its Competitors AxoGen SiBone Bioventus AVANOS MEDICAL ZimVie OrthoPediatrics Treace Medical Concepts CeriBell Semler Scientific Delcath Systems CVRx (NASDAQ:CVRX) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings. Does the media favor CVRX or AXGN? In the previous week, AxoGen had 7 more articles in the media than CVRx. MarketBeat recorded 9 mentions for AxoGen and 2 mentions for CVRx. CVRx's average media sentiment score of 1.56 beat AxoGen's score of 0.83 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive AxoGen 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Which has stronger earnings & valuation, CVRX or AXGN? AxoGen has higher revenue and earnings than CVRx. AxoGen is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$51.29M4.01-$59.97M-$2.10-3.75AxoGen$187.34M4.03-$9.96M-$0.10-164.10 Do institutionals and insiders have more ownership in CVRX or AXGN? 75.3% of CVRx shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 18.9% of CVRx shares are owned by insiders. Comparatively, 2.8% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, CVRX or AXGN? CVRx has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.02, indicating that its share price is 2% more volatile than the S&P 500. Do analysts recommend CVRX or AXGN? CVRx presently has a consensus target price of $14.00, indicating a potential upside of 77.89%. AxoGen has a consensus target price of $26.00, indicating a potential upside of 58.44%. Given CVRx's higher probable upside, equities analysts clearly believe CVRx is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86AxoGen 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CVRX or AXGN more profitable? AxoGen has a net margin of -2.29% compared to CVRx's net margin of -95.61%. AxoGen's return on equity of -4.43% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-95.61% -79.31% -40.96% AxoGen -2.29%-4.43%-2.34% SummaryAxoGen beats CVRx on 10 of the 17 factors compared between the two stocks. Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$205.80M$6.72B$5.78B$10.18BDividend YieldN/A1.20%5.73%4.60%P/E Ratio-3.7526.0175.5226.02Price / Sales4.01187.86459.7191.38Price / CashN/A22.1825.8129.91Price / Book2.695.0013.206.25Net Income-$59.97M$176.38M$3.29B$270.76M7 Day Performance-1.01%0.64%0.83%2.54%1 Month Performance11.95%2.47%4.72%5.73%1 Year Performance0.25%10.96%74.39%25.85% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx2.7324 of 5 stars$7.87-4.5%$14.00+77.9%+0.3%$205.80M$51.29M-3.75160News CoveragePositive NewsAXGNAxoGen2.6637 of 5 stars$16.04+0.4%$26.00+62.1%+19.0%$735.28M$187.34M-160.38450Positive NewsSIBNSiBone3.7791 of 5 stars$16.13-1.0%$23.67+46.7%-0.2%$702.77M$167.18M-28.80350Positive NewsBVSBioventus3.3102 of 5 stars$7.21+0.3%$13.75+90.7%-35.3%$596.12M$564.14M-11.821,200Positive NewsAVNSAVANOS MEDICAL2.0957 of 5 stars$12.41-2.5%N/A-49.0%$590.24M$687.80M-1.232,227Positive NewsZIMVZimVie1.2532 of 5 stars$18.89+0.2%$17.75-6.0%+14.7%$531.77M$449.75M-26.991,770Positive NewsKIDSOrthoPediatrics4.3395 of 5 stars$20.91flat$34.14+63.3%-39.1%$524.29M$204.73M-11.68200TMCITreace Medical Concepts2.5562 of 5 stars$7.11-0.8%$9.83+38.3%+41.0%$452.95M$209.36M-9.00250Positive NewsCBLLCeriBell2.5151 of 5 stars$12.06+2.2%$32.14+166.5%N/A$432.64M$65.44M-4.03N/ASMLRSemler Scientific2.9684 of 5 stars$28.29+0.6%$81.75+189.0%+12.6%$416.31M$56.29M11.64120DCTHDelcath Systems3.0617 of 5 stars$11.55-0.9%$24.50+112.1%+13.6%$407.53M$37.21M231.0060Positive News Related Companies and Tools Related Companies AXGN Competitors SIBN Competitors BVS Competitors AVNS Competitors ZIMV Competitors KIDS Competitors TMCI Competitors CBLL Competitors SMLR Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CVRX) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
